EP3655544A4 - Méthode de diagnostic d'une dysbiose - Google Patents

Méthode de diagnostic d'une dysbiose Download PDF

Info

Publication number
EP3655544A4
EP3655544A4 EP18835137.3A EP18835137A EP3655544A4 EP 3655544 A4 EP3655544 A4 EP 3655544A4 EP 18835137 A EP18835137 A EP 18835137A EP 3655544 A4 EP3655544 A4 EP 3655544A4
Authority
EP
European Patent Office
Prior art keywords
dysbiosis
diagnosing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18835137.3A
Other languages
German (de)
English (en)
Other versions
EP3655544A1 (fr
Inventor
Margaret SMITH
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smartdna Pty Ltd
Original Assignee
Smartdna Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017902786A external-priority patent/AU2017902786A0/en
Application filed by Smartdna Pty Ltd filed Critical Smartdna Pty Ltd
Publication of EP3655544A1 publication Critical patent/EP3655544A1/fr
Publication of EP3655544A4 publication Critical patent/EP3655544A4/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/06—Quantitative determination
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP18835137.3A 2017-07-17 2018-07-17 Méthode de diagnostic d'une dysbiose Pending EP3655544A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2017902786A AU2017902786A0 (en) 2017-07-17 Method of diagnosing a dysbiosis
PCT/AU2018/050748 WO2019014714A1 (fr) 2017-07-17 2018-07-17 Méthode de diagnostic d'une dysbiose

Publications (2)

Publication Number Publication Date
EP3655544A1 EP3655544A1 (fr) 2020-05-27
EP3655544A4 true EP3655544A4 (fr) 2021-08-11

Family

ID=65014822

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18835137.3A Pending EP3655544A4 (fr) 2017-07-17 2018-07-17 Méthode de diagnostic d'une dysbiose

Country Status (7)

Country Link
US (2) US11447811B2 (fr)
EP (1) EP3655544A4 (fr)
JP (2) JP7317821B2 (fr)
CN (1) CN110892081A (fr)
AU (4) AU2018253466B2 (fr)
SG (1) SG11201913701VA (fr)
WO (1) WO2019014714A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3072032A1 (fr) * 2017-08-07 2019-02-14 Finch Therapeutics, Inc. Compositions et procedes pour le maintien et la restauration d'une barriere intestinale saine
WO2020071660A1 (fr) * 2018-10-01 2020-04-09 한국생명공학연구원 Composition anti-âge contenant comme principe actif une souche d'akkermansia muciniphila ou une culture de cette dernière
CN111647652A (zh) * 2019-03-04 2020-09-11 中国医学科学院药物研究所 一种与肾病综合征相关的肠道菌属Catabacter及其应用
JP2022528466A (ja) * 2019-04-03 2022-06-10 フォーディー ファーマ コーク リミテッド 疾患を診断する方法
US11884958B2 (en) 2019-04-30 2024-01-30 Mayo Foundation For Medical Education And Research Assessing and treating functional gastrointestinal disorders
CN110838365A (zh) * 2019-09-27 2020-02-25 康美华大基因技术有限公司 肠易激综合症相关菌群标志物及其试剂盒
US11744866B2 (en) 2020-03-18 2023-09-05 Sabine Hazan Methods of preventing and treating COVID-19 infection with probiotics
US20220290226A1 (en) * 2020-03-20 2022-09-15 Zoe Global Limited Microbiome fingerprints, dietary fingerprints, and microbiome ancestry, and methods of their use
CN111411151B (zh) * 2020-04-22 2021-01-12 中国医学科学院北京协和医院 一种肌少症的肠道菌群标志物及其应用
TW202214273A (zh) * 2020-06-15 2022-04-16 香港中文大學 細菌在孩童發育評估和治療的應用
CN112111586A (zh) * 2020-08-11 2020-12-22 康美华大基因技术有限公司 一种克罗恩病相关微生物标志物集及其应用
CN114381534B (zh) * 2021-11-25 2024-07-12 杭州拓宏生物科技有限公司 脂肪肝标志微生物及其应用
WO2023114384A1 (fr) * 2021-12-16 2023-06-22 Sapient Bioanalytics, Llc Systèmes et procédés d'identification d'espèces microbiennes et d'amélioration de la santé
CN114317674B (zh) * 2021-12-31 2024-04-12 青岛锐翌精准医学检验有限公司 类风湿性关节炎标志微生物及其应用
CN114496278B (zh) * 2022-01-12 2022-09-27 广州保量医疗科技有限公司 肠道菌群移植配型的数据处理方法、系统、设备及介质
WO2023156628A1 (fr) * 2022-02-18 2023-08-24 Universiteit Antwerpen Procédés de prédiction de la gravité d'une dysbiose provoquée par un traitement avec un antibiotique
CN114752536A (zh) * 2022-05-18 2022-07-15 中国水产科学研究院珠江水产研究所 罗姆布茨菌my01及其应用
EP4357779A1 (fr) * 2022-10-21 2024-04-24 Mars, Incorporated Trouble inflammatoire chez les félidés

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011043654A1 (fr) * 2009-10-05 2011-04-14 Aak Patent B.V. Procédé de diagnostic du syndrome du côlon irritable
WO2016065075A1 (fr) * 2014-10-21 2016-04-28 uBiome, Inc. Procédé et système de diagnostic et de thérapie fondés sur le microbiome

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9709728D0 (en) 1997-05-13 1997-07-02 Dynal As Single step method
GB0001450D0 (en) 2000-01-21 2000-03-08 Genpoint As Cell isolation method
EP2241318B1 (fr) * 2006-05-01 2012-12-19 Napo Pharmaceuticals, Inc. Méthode de traitement du syndrome du côlon irritable à constipation prédominante
GB201021399D0 (en) 2010-12-16 2011-01-26 Genetic Analysis As Oligonucleotide probe set and methods of microbiota profiling
WO2014036182A2 (fr) 2012-08-29 2014-03-06 California Institute Of Technology Diagnostic et traitement du trouble du spectre autistique
JP2016501852A (ja) * 2012-11-26 2016-01-21 トーマス・ジュリアス・ボロディ 糞便微生物叢の回復のための組成物、ならびにそれらを作製および使用する方法
EP2971127B1 (fr) 2013-03-14 2018-02-28 University Of Ottawa Procédés de diagnostic et de traitement de maladie intestinale inflammatoire
EP2967077A4 (fr) 2013-03-15 2016-09-14 Seres Therapeutics Inc Compositions microbiennes et procédés associés basés sur un réseau
EP3140313B1 (fr) * 2014-05-04 2020-02-26 Salix Pharmaceuticals, Inc. Microbiote du syndrome du côlon irritable et utilisations associées
WO2016033439A2 (fr) 2014-08-28 2016-03-03 Yale University Compositions et méthodes pour le traitement d'une maladie ou d'un trouble inflammatoire
US10265009B2 (en) 2014-10-21 2019-04-23 uBiome, Inc. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features
JP2016214108A (ja) * 2015-05-15 2016-12-22 森永乳業株式会社 腸内菌叢の年代判定方法及び菌群のスクリーニング方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011043654A1 (fr) * 2009-10-05 2011-04-14 Aak Patent B.V. Procédé de diagnostic du syndrome du côlon irritable
WO2016065075A1 (fr) * 2014-10-21 2016-04-28 uBiome, Inc. Procédé et système de diagnostic et de thérapie fondés sur le microbiome

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANA DURBÁN ET AL: "Structural alterations of faecal and mucosa-associated bacterial communities in irritable bowel syndrome", ENVIRONMENTAL MICROBIOLOGY REPORTS, vol. 4, no. 2, 1 April 2012 (2012-04-01), GB, pages 242 - 247, XP055653930, ISSN: 1758-2229, DOI: 10.1111/j.1758-2229.2012.00327.x *
FRANCESCO STRATI ET AL: "New evidences on the altered gut microbiota in autism spectrum disorders", MICROBIOME, BIOMED CENTRAL LTD, LONDON, UK, vol. 5, no. 1, 22 February 2017 (2017-02-22), pages 1 - 11, XP021242477, DOI: 10.1186/S40168-017-0242-1 *
L RIGSBEE: "Quantitative Profi ling of Gut Microbiota of Children With Diarrhea-Predominant Irritable Bowel Syndrome", AMERICAN JOURNAL OF GASTROENTEROLOGY, 18 September 2012 (2012-09-18) - 18 September 2012 (2012-09-18), pages 1740 - 1751, XP055506947, Retrieved from the Internet <URL:https://www.nature.com/articles/ajg2012287.pdf> [retrieved on 20180913] *
MIRJANA RAJILIĆ-STOJANOVIĆ ET AL: "Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples From Patients With Irritable Bowel Syndrome", GASTROENTEROLOGY, vol. 141, no. 5, 1 November 2011 (2011-11-01), pages 1792 - 1801, XP055018598, ISSN: 0016-5085, DOI: 10.1053/j.gastro.2011.07.043 *

Also Published As

Publication number Publication date
AU2020202974A1 (en) 2020-05-21
AU2019203763A1 (en) 2019-06-20
JP2020527055A (ja) 2020-09-03
JP7317821B2 (ja) 2023-07-31
AU2023202551A1 (en) 2023-05-18
EP3655544A1 (fr) 2020-05-27
JP2023089141A (ja) 2023-06-27
SG11201913701VA (en) 2020-02-27
US11447811B2 (en) 2022-09-20
US20200181674A1 (en) 2020-06-11
US20230130204A1 (en) 2023-04-27
CN110892081A (zh) 2020-03-17
AU2018253466A1 (en) 2019-01-31
WO2019014714A1 (fr) 2019-01-24
AU2018253466B2 (en) 2019-03-28
AU2020202974B2 (en) 2023-02-02
AU2019203763B2 (en) 2020-02-06

Similar Documents

Publication Publication Date Title
EP3655544A4 (fr) Méthode de diagnostic d&#39;une dysbiose
EP3324196A4 (fr) Appareil et procédé pour diagnostiquer une défaillance d&#39;un composant de commutation
EP3334965A4 (fr) Procédé d&#39;essai d&#39;un tuyau souple non lié
EP3592473A4 (fr) Méthode de piégeage humide
EP3470709A4 (fr) Procédé de fabrication de joint d&#39;étanchéité
EP3305482A4 (fr) Dispositif de diagnostic de défaillance et procédé de diagnostic de défaillance
EP3570078A4 (fr) Indicateur et procédé de fabrication d&#39;indicateur
EP3718462A4 (fr) Procédé de détection
EP3567358A4 (fr) Procédé permettant de diagnostiquer un dispositif de roulement
EP3111227A4 (fr) Méthode de diagnostic d&#39;une tuberculose
EP3241644A4 (fr) Procédé d&#39;évaluation de contrainte résiduelle
EP3299133A4 (fr) Dispositif de diagnostic de défaillance et procédé de diagnostic de défaillance
EP3660500A4 (fr) Procédé de fabrication d&#39;un système d&#39;inspection par ultrasons
EP3137874B8 (fr) Procédé de diagnostic de la méningite
EP3739325A4 (fr) Procédé de mesure de contrainte résiduelle
EP3552795A4 (fr) Procédé de scellement
EP3469357A4 (fr) Procédé de diagnostic
EP3234307A4 (fr) Procédé de test de pression d&#39;un puits de forage
EP3726219A4 (fr) Méthode de diagnostic de la tuberculose
EP3703109A4 (fr) Procédé de connexion d&#39;élément
EP3697821A4 (fr) Procédé
EP3514522A4 (fr) Procédé de mesurage
EP3477298A4 (fr) Procédé de mesure
EP3421989A4 (fr) Procédé de test
EP3626387A4 (fr) Procédé de fabrication d&#39;élément

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20191216

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/68 20180101AFI20210406BHEP

Ipc: G01N 33/50 20060101ALI20210406BHEP

Ipc: G01N 33/569 20060101ALI20210406BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20210708

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/68 20180101AFI20210702BHEP

Ipc: G01N 33/50 20060101ALI20210702BHEP

Ipc: G01N 33/569 20060101ALI20210702BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20240801